Search Results - "Ozcelik, Melike"

KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential by Eser, Metin, Hekimoglu, Gulam, Yarar, Murat Hakki, Canbek, Sezin, Ozcelik, Melike

“…Lung cancer remains a significant health challenge, characterized by aberrant tissue growth within the pulmonary system. Early carcinogenic events often…”
Get full text

An exceptionally rare case of metastatic high‐grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound‐guided fine‐needle aspiration: A diagnostic challenge by Koyuncuer, Ali, Sayar, Süleyman, Zemheri, Itır Ebru, Özdil, Kamil, Özçelik, Melike

“…Metastases to the pancreas are rare and can be confused with the primary adenocarcinoma of the pancreas. Metastasis of renal pelvis urothelial carcinomas to…”
Get full text

Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism by Çelik, Mehmet, Özçelik, Serhat, Baş, Süleyman, Sariaydin, Mehmet, Özçelik, Melike, Gozu, Hulya

“…We aimed to investigate the role of testosterone to estradiol ratio in predicting the effectiveness of human chorionic gonadotropin and testosterone treatments…”
Get full text

Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? by Özyurt, Esra, Özçelik, Serhat, Sürmeli, Heves, Çelik, Mehmet, Ayhan, Murat, Özçelik, Melike

“…Introduction Nivolumab is a human immunoglobulin G4 monoclonal antibody that inhibits programmed cell death-1 activity by binding to the programmed cell…”
Get full text

Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience by Özçelik, Serhat, Çelik, Mehmet, Vural, Aşkı, Aydın, Bünyamin, Özçelik, Melike, Gozu, Hulya

“…To evaluate the efficacy and safety of transition from premixed and intensive insulin to twice-daily insulin degludec/aspart (IDegAsp) co-formulation in…”
Get full text

Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? by Odabas, Hatice, Dogan, Akif, Ozcelik, Melike, Yildirim, Sedat, Ozkerim, Ugur, Turan, Nedim, Yildirim, Mahmut Emre, Gumus, Mahmut

“…This investigation aimed to determine the impacts of concurrent proton pump inhibitors (PPIs) on progression-free survival (PFS) in patients with hormone…”
Get full text

The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma by Arak, Haci, Erkiliç, Suna, Yaslikaya, Şendağ, Eylemer Mocan, Eda, Aktaş, Gökmen, Özdemir, Melek, Semiz, Hüseyin Salih, Kiliçkap, Saadettin, Özalp, Faruk Recep, Sever, Özlem Nuray, Akdağ, Goncagül, Ağaoğlu, Ahmet Burak, Özçelik, Melike, Sari, Murat, Arcagök, Murat, Anik, Hicran, Yayla, Şaziye Burçak, Sever, Nadiye, Açar, Fatma Pinar, Bayrakçi, İsmail, Turhal, Serdar, Ayhan, Murat, Kuş, Tülay

“…Our aim was to assess the efficacy of adjuvant programmed cell death protein-1 (PD-1) inhibitors and compare the other adjuvant treatments in patients with…”
Get full text

Psychological impacts of COVID-19 pandemic in cancer patients on active treatment by Koca, Sinan, Koca, Esra, Okten, Ilker N., Orengül, Fatma FC, Oztürk, Akın, Ozçelik, Melike, Oyman, Abdilkerim, Çil, Ibrahim, Gümüş, Mahmut

“…Although cancer patients have a high risk of exposing COVID-19 and developing severe complications, they have to receive active treatment. We aimed to…”
Get full text

Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study by Koca, Sinan, Beşiroğlu, Mehmet, Özçelik, Melike, Karaca, Mustafa, Bilici, Mehmet, Hacıoğlu, Bekir, Doğu, Gamze G, Kaplan, Nihal B, Oruç, Zeynep, Aydın, Dinçer, Dane, Faysal

“…Purpose Soft tissue sarcomas are associated with a poor prognosis and low chemotherapeutic efficiency. Pazopanib is an orally available multi-tyrosine kinase…”
Get full text

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis by Oyman, Abdilkerim, Başak, Mustafa, Özçelik, Melike, Özyükseler, Deniz Tataroğlu, Işık, Selver, Yıldırım, Mahmut Emre

“…Purpose The aim of this study was to evaluate the efficacy of abiraterone in patients with castration‐resistant metastatic prostate cancer. Materials and…”
Get full text

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas by Aydin, Dincer, Kefeli, Umut, Ozcelik, Melike, Erdem, Gokmen Umut, Sendur, Mehmet Ali, Yildirim, Mahmut Emre, Oven, Basak Bala, Bilici, Ahmet, Gumus, Mahmut

“…Background and Objectives: Small bowel adenocarcinomas (SBAs) are rare tumors of the gastrointestinal system. Lymph node metastasis in patients with curatively…”
Get full text

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer by Esen, Selin Akturk, Ergun, Yakup, Erol, Cihan, Arikan, Rukiye, Er, Muhammed Muhiddin, Atci, Muhammed Mustafa, Topcu, Atakan, Ucar, Gokhan, Akagunduz, Baran, Aykan, Musa Baris, Ozen, Mirac, Baytemur, Naziyet Kose, Ozcelik, Melike, Sahin, Elif, Guven, Denizcan, Menekse, Serkan, Ak, Naziye, Teker, Fatih, Kut, Engin, Sakalar, Teoman, Alan, Ozkan, Kacan, Turgut, Turhal, Nazim Serdar, Kilickap, Saadettin, Turker, Sema, Sendur, Mehmet Ali Nahit, Kostek, Osman, Karaagac, Mustafa, Sakin, Abdullah, Turk, Haci Mehmet, Caglayan, Dilek, Cihan, Sener, Acikgoz, Yusuf, Uncu, Dogan

“…Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of human epidermal growth factor receptor 2…”
Get full text

Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less by Özaslan, Ersin, Karaca, Halit, Koca, Sinan, Sevinç, Alper, Hacioğlu, Bekir, Özkan, Metin, Özçelik, Melike, Duran, Ayşe O, Hacibekiroğlu, İlhan, Yildiz, Yaşar, Tanriverdi, Özgür, Menekşe, Serkan, Aksoy, Asude, Bozkurt, Oktay, Urvay, Semiha, Uysal, Mükremin, Demir, Hacer, Çiltaş, Aydin, Dane, Faysal

“…The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and…”
Get full text

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant by Özçelik, Melike, Ercelep, Özlem, Keser, Sevinç, Özdemir Barışık, Nagehan, Başar, Merve, Odabaş, Hatice, Oyman, Abdilkerim, Işık, Selver, Özçelik, Serhat, Aliustaoğlu, Mehmet

“…Protein tyrosine kinase-7, a regulatory protein in the Wnt signaling pathway, was highly overexpressed in various cancer types and assumed to be related to…”
Get full text

Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study by Başoğlu, Tuğba, Sakin, Abdullah, Erol, Cihan, Özden, Ercan, Çabuk, Devrim, Çılbır, Ebru, Tataroğlu Özyükseler, Deniz, Ayhan, Murat, Şendur, Mehmet Ali, Dogan, Mutlu, Öksüzoğlu, Berna, Eryılmaz, Melek Karakurt, Er, Özlem, Taşçı, Elif Şenocak, Özyurt, Neslihan, Dülgar, Özgecan, Özen, Miraç, Hacıbekiroğlu, İlhan, Öner, İrem, Bekmez, Esma Türkmen, Çağrı Yıldırım, Hasan, Yalçın, Şuayib, Paydaş, Semra, Yekedüz, Emre, Aksoy, Asude, Özçelik, Melike, Oyman, Abdilkerim, Almuradova, Elvina, Karabulut, Bülent, Demir, Nazan, Dinçer, Murat, Özdemir, Nuriye, Erdem, Dilek, Ak, Naziye, İnal, Ali, Salim, Derya Kıvrak, Deniz, Gülhan İpek, Şakalar, Teoman, Gülmez, Ahmet, Kaçan, Turgut, Özdemir, Özlem, Alan, Özkan, Ünal, Çağlar, Karakaş, Yusuf, Turhal, Serdar, Yumuk, Perran Fulden

“…Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share…”
Get full text

Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer by Ercelep, Özlem, Tataroğlu, Deniz, Özçelik, Melike, Sürmeli, Heves, Değirmenci, Mustafa, İnanç, Mevlüde, Aliustaoğlu, Mehmet, Gümüş, Mahmut

“…To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish…”
Get full text

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma by Aydin, Dincer, Sendur, Mehmet Ali, Kefeli, Umut, Ustaalioglu, Basak Bala, Aydin, Ozhan, Yildirim, Emre, Işik, Deniz, Ozcelik, Melike, Surmeli, Heves, Oyman, Abdilkerim, Isik, Selver, Sener, Nur, Ercelep, Ozlem, Hatice, Odabas, Aliustaoglu, Mehmet, Gumus, Mahmut

“…Abstract Background SBAs are rarely seen tumors.Data regarding the use of chemotherapy together with bevacizumab in advanced SBA patients are lacking Materials…”
Get full text

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group) by Erol, Cihan, Sakin, Abdullah, Başoğlu, Tuğba, Özden, Ercan, Çabuk, Devrim, Doğan, Mutlu, Öksüzoğlu, Berna, Yıldırım, Hasan Çağrı, Öner, İrem, Eryılmaz, Melek Karakurt, Dülgar, Özgecan, Aydın, Dinçer, Doğan, Neslihan, Özen, Miraç, Hacıbekiroğlu, İlhan, Özdemir, Nuriye, Gürler, Fatih, Paksoy, Nail, Karabulut, Senem, Aksoy, Asude, Hızal, Mutlu, Kahraman, Seda, Şen, Erdem, Paydaş, Semra, Çılbır, Ebru, Fırat, Feyza, Akdeniz, Nadiye, Özçelik, Melike, Oyman, Abdilkerim, Baytemür, Naziyet Köse, Acar, Ramazan, Almuradova, Elvina, Karabulut, Bülent, Şakalar, Teoman, Arak, Hacı, Değerli, Ezgi, Türker, Sema, Alan, Özkan, Er, Özlem, Taşçı, Elif Şenocak, Demir, Nazan, Çavdar, Eyyüp, Turhal, Serdar, Dede, Didem Şener, Akıncı, Muhammed Bülent, Yalçın, Bülent, Yumuk, Fulden, Yalçın, Şuayib, Şendur, Mehmet Ali Nahit

“…Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic…”
Get full text

BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure by Özçelik, Serhat, Bircan, Rifat, Sarıkaya, Şükran, Gül, Aylin Ege, Aydın, Büşra, Özçelik, Melike, Çelik, Mehmet, Dayan, Akın, Tütüncü, Yasemin, Cengiz, Hasret, Karadayı, Nimet, Gözü, Hülya Ilıksu

“…INTRODUCTION: BRAFV600E activating mutation is the most frequent genetic abnormality in the pathogenesis of papillary thyroid carcinoma. We aimed to evaluate…”
Get full text

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas by Cicin, İrfan, Özatlı, Tahsin, Türkmen, Esma, Özturk, Türkan, Özçelik, Melike, Çabuk, Devrim, Gökdurnalı, Ayşe, Balvan, Özlem, Yıldız, Yaşar, Şeker, Metin, Özdemir, Nuriye, Yapar, Burcu, Tanrıverdi, Özgür, Günaydin, Yusuf, Menekşe, Serkan, Öksüzoğlu, Berna, Aksoy, Asude, Erdogan, Bülent, Bekir Hacıoglu, M, Arpaci, Erkan, Sevinç, Alper

“…Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more…”
Get full text